Generic Name and Formulations:
Erenumab-aooe 70mg/mL; soln for SC inj; preservative-free.
RECENT UPDATESMonograph added.
Indications for AIMOVIG:
Prophylaxis of migraine.
Give by SC inj into abdomen, thigh, or upper arm. 70mg once monthly; some patients may benefit from 140mg (given as 2 consecutive 70mg inj) once monthly.
Do not inj into tender, bruised, red, or hard areas. Latex allergy. Elderly. Pregnancy. Nursing mothers.
Calcitonin gene-related peptide (CGRP) receptor antagonist.
Inj site reactions, constipation, cramps, muscle spasms.
Single-dose prefilled SureClick autoinjectors—1, 2; Single-dose prefilled syringes—1, 2
Neurology Advisor Articles
- Visual Association Test, MMSE Highly Predictive of Dementia in Older Adults
- Epilepsy's Mobility Problem: Advocating for Changes in Transportation Laws, Public Resources
- The Future of Freezing of Gait in Parkinson's: Exploring Potential Treatments and Preventive Strategies
- Women With Epilepsy More Likely to Have Major Depressive Disorder
- Some Common Allergies Linked to Odds of Autism in Children
- CAPPRI Scale is Feasible for Assessing Health-Related Quality of Life in Diabetic Distal Sensorimotor Polyneuropathy
- Long-Term Type 1 Diabetes Associated With Cognitive Decline
- White Matter Hyperintensities in RCVS Vary Over Time
- Disrupted Thalamo-Striato-Hypothalamic Function May Serve as a Good Biomarker for Parkinson Disease
- Levetiracetam Effective as Episodic Migraine Prophylactic